127 related articles for article (PubMed ID: 36578913)
1. Cost-Effectiveness and Distributional Impact of Opportunistic Screening for People at High-Risk of Cardiovascular Disease in Sri Lanka: A Modelling Study.
Wijemunige N; Rannan-Eliya RP; Maurer J; O'Donnell O
Glob Heart; 2022; 17(1):89. PubMed ID: 36578913
[TBL] [Abstract][Full Text] [Related]
2. Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey data.
Wijemunige N; Rannan-Eliya RP; van Baal P; O'Donnell O
BMC Public Health; 2023 Sep; 23(1):1792. PubMed ID: 37715157
[TBL] [Abstract][Full Text] [Related]
3. Budget impact and cost-effectiveness analyses of the COBRA-BPS multicomponent hypertension management programme in rural communities in Bangladesh, Pakistan, and Sri Lanka.
Finkelstein EA; Krishnan A; Naheed A; Jehan I; de Silva HA; Gandhi M; Lim CW; Chakma N; Ediriweera DS; Khan J; Kasturiratne A; Hirani S; Solayman AKM; Jafar TH;
Lancet Glob Health; 2021 May; 9(5):e660-e667. PubMed ID: 33751956
[TBL] [Abstract][Full Text] [Related]
4. Community intervention for cardiovascular disease risk factors in Kalutara, Sri Lanka.
Gamlath L; Nandasena S; Silva P; Morrell S; Linhart C; Lin S; Sharpe A; Nathan S; Taylor R
BMC Cardiovasc Disord; 2020 Apr; 20(1):203. PubMed ID: 32345219
[TBL] [Abstract][Full Text] [Related]
5. Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial.
Lung T; Jan S; de Silva HA; Guggilla R; Maulik PK; Naik N; Patel A; de Silva AP; Rajapakse S; Ranasinghe G; Prabhakaran D; Rodgers A; Salam A; Selak V; Stepien S; Thom S; Webster R; Lea-Laba T;
Lancet Glob Health; 2019 Oct; 7(10):e1359-e1366. PubMed ID: 31477545
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analyses of self-harm strategies aimed at reducing the mortality of pesticide self-poisonings in Sri Lanka: a study protocol.
Madsen LB; Eddleston M; Hansen KS; Pearson M; Agampodi S; Jayamanne S; Konradsen F
BMJ Open; 2015 Feb; 5(2):e007333. PubMed ID: 25724984
[TBL] [Abstract][Full Text] [Related]
7. The quality of outpatient primary care in public and private sectors in Sri Lanka--how well do patient perceptions match reality and what are the implications?
Rannan-Eliya RP; Wijemanne N; Liyanage IK; Jayanthan J; Dalpatadu S; Amarasinghe S; Anuranga C
Health Policy Plan; 2015 Mar; 30 Suppl 1():i59-74. PubMed ID: 25355069
[TBL] [Abstract][Full Text] [Related]
8. Disease burden of cardiovascular conditions complicating pregnancy in Sri Lanka: a protocol.
Hettiarachchi A; Lokunarangoda N; Agampodi T; Agampodi S
F1000Res; 2021; 10():1028. PubMed ID: 38504849
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of dengue vaccination following pre-vaccination serological screening in Sri Lanka.
Perera S; John D; Senanayaka B
Int J Technol Assess Health Care; 2019; 35(6):427-435. PubMed ID: 31625496
[TBL] [Abstract][Full Text] [Related]
10. Use of a public-private partnership in malaria elimination efforts in Sri Lanka; a case study.
Fernando D; Wijeyaratne P; Wickremasinghe R; Abeyasinghe RR; Galappaththy GNL; Wickremasinghe R; Hapugoda M; Abeywickrema WA; Rodrigo C
BMC Health Serv Res; 2018 Mar; 18(1):202. PubMed ID: 29566691
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006.
Katulanda P; Dissanayake HA; De Silva SDN; Katulanda GW; Liyanage IK; Constantine GR; Sheriff R; Matthews DR
J Clin Lipidol; 2018; 12(2):447-454. PubMed ID: 29429894
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study.
Amadi C; Lawal F; Ajiboye W; Agbim R; Mbakwem A; Ajuluchukwu J; Oke DA
Int J Clin Pharm; 2020 Dec; 42(6):1469-1479. PubMed ID: 32960427
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a Diabetes Risk Score for screening undiagnosed diabetes in Sri Lanka (SLDRISK).
Katulanda P; Hill NR; Stratton I; Sheriff R; De Silva SD; Matthews DR
BMC Endocr Disord; 2016 Jul; 16(1):42. PubMed ID: 27456082
[TBL] [Abstract][Full Text] [Related]
14. Economic costs of alcohol use in Sri Lanka.
Ranaweera S; Amarasinghe H; Chandraratne N; Thavorncharoensap M; Ranasinghe T; Karunaratna S; Kumara D; Santatiwongchai B; Chaikledkaew U; Abeykoon P; De Silva A
PLoS One; 2018; 13(6):e0198640. PubMed ID: 29879178
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka.
Karunarathna N; Hettiarachchi M
Value Health Reg Issues; 2021 May; 24():181-186. PubMed ID: 33831793
[TBL] [Abstract][Full Text] [Related]
16. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
[TBL] [Abstract][Full Text] [Related]
17. Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis.
Collins B; Kypridemos C; Cookson R; Parvulescu P; McHale P; Guzman-Castillo M; Bandosz P; Bromley H; Capewell S; O'Flaherty M
Prev Med; 2020 Jan; 130():105879. PubMed ID: 31678586
[TBL] [Abstract][Full Text] [Related]
18. Cost of malaria control in Sri Lanka.
Konradsen F; Steele P; Perera D; van der Hoek W; Amerasinghe PH; Amerasinghe FP
Bull World Health Organ; 1999; 77(4):301-9. PubMed ID: 10327708
[TBL] [Abstract][Full Text] [Related]
19. Demand for private healthcare in a universal public healthcare system: empirical evidence from Sri Lanka.
Pallegedara A; Grimm M
Health Policy Plan; 2017 Nov; 32(9):1267-1284. PubMed ID: 28981660
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect costs for hospitalized patients with dengue in Southern Sri Lanka.
Weerasinghe NP; Bodinayake CK; Wijayaratne WMDGB; Devasiri IV; Dahanayake NJ; Kurukulasooriya MRP; Premamali M; Sheng T; Nicholson BP; Ubeysekera HA; de Silva AD; Østbye T; Woods CW; Tillekeratne LG; Nagahawatte AS
BMC Health Serv Res; 2022 May; 22(1):657. PubMed ID: 35578247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
